Cargando…

Medication Regularity of Traditional Chinese Medicine in the Treatment of Aplastic Anemia Based on Data Mining

OBJECTIVE: Aplastic anemia (AA) is an uncommon disease, characterized by pancytopenia and hypocellular bone marrow, but it is common in the blood system. The medication rules of traditional Chinese medicine (TCM) in the treatment of AA are not clear, for which it is worth exploring the medication ru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Nanxi, Zhang, Xujie, Wu, Dijiong, Hu, Zhiping, Liu, Wenbin, Deng, Shu, Ye, Baodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436587/ https://www.ncbi.nlm.nih.gov/pubmed/36062179 http://dx.doi.org/10.1155/2022/1605359

Ejemplares similares

The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia
por: Zhu, Ningning, et al.
Publicado: (2018)

A composite mouse model of aplastic anemia complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
por: Dijiong, Wu, et al.
Publicado: (2019)

Traditional Chinese medicine for treating aplastic anemia
por: Guan, Jing, et al.
Publicado: (2023)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Differentiation of Yin, Yang and Stasis Syndromes in Severe Aplastic Anemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Correlation with Iron Metabolism, cAMP/cGMP, 17-OH-CS and Thyroxine
por: Hu, Huijin, et al.
Publicado: (2021)

Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway
por: Li, Hangchao, et al.
Publicado: (2022)

Acute rhabdomyolysis in hepatitis-associated aplastic anemia patient undergoing allogeneic hematopoietic stem-cell transplantation: case report and literature review
por: Li, Yuzhu, et al.
Publicado: (2022)

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study
por: Shen, Yingying, et al.
Publicado: (2023)

Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis
por: Liu, Shan, et al.
Publicado: (2016)

Analysis of prescription medication rules of traditional Chinese medicine for bradyarrhythmia treatment based on data mining
por: Wang, Xujie, et al.
Publicado: (2022)

Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study
por: Liu, Qi, et al.
Publicado: (2022)

Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin
por: Liu, Wenbin, et al.
Publicado: (2014)

Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis
por: Dou, Zhili, et al.
Publicado: (2021)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Quantifying Bone Marrow Fat Fraction and Iron by MRI for Distinguishing Aplastic Anemia from Myelodysplastic Syndromes
por: Zeng, Zhaolong, et al.
Publicado: (2021)

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia
por: Gao, Xuan, et al.
Publicado: (2022)

Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre
por: Shen, Yingying, et al.
Publicado: (2023)

Perspective and Experience of Patients with Aplastic Anemia on Medication Adherence
por: Li, Hangting, et al.
Publicado: (2023)

Idiopathic Aplastic Anemia: An Update
por: Solomou, Elena E.
Publicado: (2019)

Exploratory Compatibility Regularity of Traditional Chinese Medicine on Osteoarthritis Treatment: A Data Mining and Random Walk-Based Identification
por: Zhou, Qiao, et al.
Publicado: (2021)

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia
por: Contejean, Adrien, et al.
Publicado: (2019)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

Osteonecrosis of the hip in patients with aplastic anemia.
por: Park, Jeongmi, et al.
Publicado: (2002)

Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010)

Ecthyma gangrenosum associated with aplastic anemia.
por: Chun, W. H., et al.
Publicado: (1996)

Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013)

Child with aplastic anemia: Anesthetic management
por: Kaur, Manpreet, et al.
Publicado: (2012)

Recent advances in treatment of aplastic anemia
por: Shin, Seung Hwan, et al.
Publicado: (2014)

Aplastic anemia in adult and pediatric hematology
por: Niemeyer, Charlotte
Publicado: (2019)

Aplastic Anemia in Triple X Syndrome
por: Aldarwish, Mohammed, et al.
Publicado: (2023)

Study on Medication Rules of Traditional Chinese Medicine in Treating Constipation through Data Mining and Network Pharmacology
por: Xu, Shu-Min, et al.
Publicado: (2022)

First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia
por: Shen, Yingying, et al.
Publicado: (2021)

Reduced IL-33 plasma levels in aplastic anemia
por: Sun, Ming, et al.
Publicado: (2015)

Chinese Herbal Medicine Therapy Reduces the Risks of Overall and Anemia-Related Mortalities in Patients With Aplastic Anemia: A Nationwide Retrospective Study in Taiwan
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
por: Chang, Hong, et al.
Publicado: (2023)

Aplastic anemia in a petrochemical factory worker.
por: Baak, Y M, et al.
Publicado: (1999)

An Unusual Case of Aplastic Anemia Caused by Temozolomide
por: Comez, Gazi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_88n65luacsogtb8nn8uchj78u2